What is the risk of major congenital abnormalities among women on antiretroviral therapy?

AIDS. 2018 Jan 28;32(3):403-404. doi: 10.1097/QAD.0000000000001711.

Authors

Rebecca M Zash^{1

2}, Paige Williams³, Lewis B Holmes⁴

Affiliations

¹ Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center.
² Department of Immunology and Infectious Diseases.
³ Departments of Biostatistics and Epidemiology, Harvard TH Chan School of Public Health.
⁴ Medical Genetics Unit, MassGeneral Hospital for Children, Department of Pediatrics, Boston, Massachusetts, USA.

PMID: 29309347
DOI: 10.1097/QAD.0000000000001711

No abstract available

MeSH terms

Abnormalities, Drug-Induced / epidemiology*
Anti-Retroviral Agents / administration & dosage
Anti-Retroviral Agents / adverse effects*
Antiretroviral Therapy, Highly Active / adverse effects*
Female
HIV Infections / drug therapy*
Humans
Pregnancy
Risk Assessment

Substances

Anti-Retroviral Agents